SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-003350
Filing Date
2017-12-19
Accepted
2017-12-19 15:55:07
Documents
2
Period of Report
2017-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannabics_8k.htm 8-K 16667
2 SALES SUPPORT AND MAINTENANCE AGREEMENT cannabics_8k-ex9901.htm EX-99.1 47962
  Complete submission text file 0001683168-17-003350.txt   65971
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 171263987
SIC: 2834 Pharmaceutical Preparations